Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth.

Rodrigues PF, Matarazzo S, Maccarinelli F, Foglio E, Giacomini A, Silva Nunes JP, Presta M, Dias AAM, Ronca R.

Front Oncol. 2018 Nov 1;8:472. doi: 10.3389/fonc.2018.00472. eCollection 2018.

PMID:
30443492
2.

NPO guidelines: what is changing, what is not, and what should?

Presta MV, Bhavani SS, Abdelmalak BB.

Minerva Anestesiol. 2018 Oct 30. doi: 10.23736/S0375-9393.18.13042-2. [Epub ahead of print]

PMID:
30394064
3.

Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2.

Presta M, Foglio E, Churruca Schuind A, Ronca R.

Front Immunol. 2018 Oct 8;9:2327. doi: 10.3389/fimmu.2018.02327. eCollection 2018. Review.

4.

Editorial overview: Lymphatic vessels: More than a draining pipeline.

Presta M, Sozzani S.

Curr Opin Immunol. 2018 Aug;53:vii-ix. doi: 10.1016/j.coi.2018.08.004. No abstract available.

PMID:
30220353
5.

Future applications of FGF/FGFR inhibitors in cancer.

Ghedini GC, Ronca R, Presta M, Giacomini A.

Expert Rev Anticancer Ther. 2018 Sep;18(9):861-872. doi: 10.1080/14737140.2018.1491795. Epub 2018 Jul 2.

PMID:
29936878
6.

Dendritic cells in inflammatory angiogenesis and lymphangiogenesis.

Bosisio D, Ronca R, Salvi V, Presta M, Sozzani S.

Curr Opin Immunol. 2018 Aug;53:180-186. doi: 10.1016/j.coi.2018.05.011. Epub 2018 Jun 4. Review.

PMID:
29879585
7.

Claudin3 is localized outside the tight junctions in human carcinomas.

Corsini M, Ravaggi A, Odicino F, Santin AD, Ravelli C, Presta M, Romani C, Mitola S.

Oncotarget. 2018 Apr 6;9(26):18446-18453. doi: 10.18632/oncotarget.24858. eCollection 2018 Apr 6.

8.

Long pentraxin 3: A novel multifaceted player in cancer.

Giacomini A, Ghedini GC, Presta M, Ronca R.

Biochim Biophys Acta Rev Cancer. 2018 Jan;1869(1):53-63. doi: 10.1016/j.bbcan.2017.11.004. Epub 2017 Nov 23. Review.

PMID:
29175552
9.

Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer.

Ronca R, Tamma R, Coltrini D, Ruggieri S, Presta M, Ribatti D.

Oncotarget. 2017 Aug 1;8(47):82583-82592. doi: 10.18632/oncotarget.19773. eCollection 2017 Oct 10.

10.

N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors.

Nawaz IM, Chiodelli P, Rezzola S, Paganini G, Corsini M, Lodola A, Di Ianni A, Mor M, Presta M.

Angiogenesis. 2018 Feb;21(1):47-59. doi: 10.1007/s10456-017-9581-6. Epub 2017 Oct 13.

PMID:
29030736
11.

3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy.

Rezzola S, Nawaz IM, Cancarini A, Ravelli C, Calza S, Semeraro F, Presta M.

Angiogenesis. 2017 Nov;20(4):629-640. doi: 10.1007/s10456-017-9575-4. Epub 2017 Sep 13.

PMID:
28905243
12.

Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis.

Chiodelli P, Rezzola S, Urbinati C, Federici Signori F, Monti E, Ronca R, Presta M, Rusnati M.

Oncogene. 2017 Nov 23;36(47):6531-6541. doi: 10.1038/onc.2017.243. Epub 2017 Aug 7.

PMID:
28783175
13.

Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach.

Presta M, Chiodelli P, Giacomini A, Rusnati M, Ronca R.

Pharmacol Ther. 2017 Nov;179:171-187. doi: 10.1016/j.pharmthera.2017.05.013. Epub 2017 May 28. Review.

PMID:
28564583
14.

U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis.

Caccuri F, Ronca R, Laimbacher AS, Berenzi A, Steimberg N, Campilongo F, Mazzuca P, Giacomini A, Mazzoleni G, Benetti A, Caselli E, Presta M, Di Luca D, Fraefel C, Caruso A.

Oncotarget. 2017 Jul 4;8(27):44533-44549. doi: 10.18632/oncotarget.17817.

15.

The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions.

Sacco A, Fenotti A, Affò L, Bazzana S, Russo D, Presta M, Malagola M, Anastasia A, Motta M, Patterson CJ, Rossi G, Imberti L, Treon SP, Ghobrial IM, Roccaro AM.

Oncotarget. 2017 May 23;8(21):35435-35444. doi: 10.18632/oncotarget.16130. Review.

16.

Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.

Rezzola S, Corsini M, Chiodelli P, Cancarini A, Nawaz IM, Coltrini D, Mitola S, Ronca R, Belleri M, Lista L, Rusciano D, De Rosa M, Pavone V, Semeraro F, Presta M.

Diabetologia. 2017 Apr;60(4):719-728. doi: 10.1007/s00125-016-4204-0. Epub 2017 Jan 13.

PMID:
28083635
17.

Endoscopic Laser Management of a Leiomyoma of the Left Main Stem Bronchus.

Bakhos C, Stavrakis C, Presta M.

J Bronchology Interv Pulmonol. 2017 Jan;24(1):e14-e16. No abstract available.

PMID:
27984395
18.

Synthetic Site-Selectively Mono-6-O-Sulfated Heparan Sulfate Dodecasaccharide Shows Anti-Angiogenic Properties In Vitro and Sensitizes Tumors to Cisplatin In Vivo.

Avizienyte E, Cole CL, Rushton G, Miller GJ, Bugatti A, Presta M, Gardiner JM, Jayson GC.

PLoS One. 2016 Aug 4;11(8):e0159739. doi: 10.1371/journal.pone.0159739. eCollection 2016.

19.

Evaluation of the Biotoxicity of Tree Wood Ashes in Zebrafish Embryos.

Consigli V, Guarienti M, Bilo F, Benassi L, Depero LE, Bontempi E, Presta M.

Zebrafish. 2016 Oct;13(5):449-55. doi: 10.1089/zeb.2016.1255. Epub 2016 Aug 3.

PMID:
27487527
20.

Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist.

Grillo E, Ravelli C, Corsini M, Ballmer-Hofer K, Zammataro L, Oreste P, Zoppetti G, Tobia C, Ronca R, Presta M, Mitola S.

Oncotarget. 2016 Jun 7;7(23):35353-68. doi: 10.18632/oncotarget.9286.

21.

COSMOS-rice technology abrogates the biotoxic effects of municipal solid waste incinerator residues.

Guarienti M, Cardozo SM, Borgese L, Lira GR, Depero LE, Bontempi E, Presta M.

Environ Pollut. 2016 Jul;214:713-721. doi: 10.1016/j.envpol.2016.04.053. Epub 2016 May 3.

PMID:
27149148
22.

Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors.

Castelli R, Giacomini A, Anselmi M, Bozza N, Vacondio F, Rivara S, Matarazzo S, Presta M, Mor M, Ronca R.

J Med Chem. 2016 May 26;59(10):4651-63. doi: 10.1021/acs.jmedchem.5b02021. Epub 2016 May 3.

PMID:
27138345
23.

Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases.

Rezzola S, Paganini G, Semeraro F, Presta M, Tobia C.

Biochim Biophys Acta. 2016 Jul;1862(7):1291-6. doi: 10.1016/j.bbadis.2016.04.009. Epub 2016 Apr 13. Review.

24.

Assessment and Molecular Characterization of Human Intestinal Parasites in Bivalves from Orchard Beach, NY, USA.

Tei FF, Kowalyk S, Reid JA, Presta MA, Yesudas R, Mayer DC.

Int J Environ Res Public Health. 2016 Mar 29;13(4):381. doi: 10.3390/ijerph13040381.

25.

Endothelial cell dysfunction in globoid cell leukodystrophy.

Belleri M, Presta M.

J Neurosci Res. 2016 Nov;94(11):1359-67. doi: 10.1002/jnr.23744. Epub 2016 Apr 1. Review.

PMID:
27037626
26.

Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.

Giacomini A, Chiodelli P, Matarazzo S, Rusnati M, Presta M, Ronca R.

Pharmacol Res. 2016 May;107:172-185. doi: 10.1016/j.phrs.2016.03.024. Epub 2016 Mar 22. Review.

PMID:
27013279
27.

A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays.

Gnutti A, Signoroni A, Leonardi R, Corsini M, Presta M, Mitola S.

Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:763-6. doi: 10.1109/EMBC.2015.7318474.

PMID:
26736374
28.

SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness.

Crottès D, Rapetti-Mauss R, Alcaraz-Perez F, Tichet M, Gariano G, Martial S, Guizouarn H, Pellissier B, Loubat A, Popa A, Paquet A, Presta M, Tartare-Deckert S, Cayuela ML, Martin P, Borgese F, Soriani O.

Cancer Res. 2016 Feb 1;76(3):607-18. doi: 10.1158/0008-5472.CAN-15-1465. Epub 2015 Dec 8.

29.

Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease.

Giacomini A, Ackermann M, Belleri M, Coltrini D, Nico B, Ribatti D, Konerding MA, Presta M, Righi M.

Angiogenesis. 2015 Oct;18(4):499-510. doi: 10.1007/s10456-015-9481-6. Epub 2015 Aug 27.

PMID:
26310512
30.

β3 Integrin Promotes Long-Lasting Activation and Polarization of Vascular Endothelial Growth Factor Receptor 2 by Immobilized Ligand.

Ravelli C, Grillo E, Corsini M, Coltrini D, Presta M, Mitola S.

Arterioscler Thromb Vasc Biol. 2015 Oct;35(10):2161-71. doi: 10.1161/ATVBAHA.115.306230. Epub 2015 Aug 20.

31.

Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy.

Ronca R, Giacomini A, Di Salle E, Coltrini D, Pagano K, Ragona L, Matarazzo S, Rezzola S, Maiolo D, Torrella R, Moroni E, Mazzieri R, Escobar G, Mor M, Colombo G, Presta M.

Cancer Cell. 2015 Aug 10;28(2):225-39. doi: 10.1016/j.ccell.2015.07.002.

32.

Revenue from single-balloon enteroscopy is driven by anesthesia: experience from a tertiary care facility.

Banerjee N, Presta M, Charous M, Gupta N.

Surg Endosc. 2016 Apr;30(4):1635-9. doi: 10.1007/s00464-015-4394-4. Epub 2015 Jul 14.

PMID:
26169643
33.

The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.

Ronca R, Giacomini A, Rusnati M, Presta M.

Expert Opin Ther Targets. 2015;19(10):1361-77. doi: 10.1517/14728222.2015.1062475. Epub 2015 Jun 30. Review.

PMID:
26125971
34.

A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers.

Giacomini A, Matarazzo S, Pagano K, Ragona L, Rezzola S, Corsini M, Di Salle E, Presta M, Ronca R.

Oncotarget. 2015 May 30;6(15):13790-802.

35.

Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy.

Dal Monte M, Rezzola S, Cammalleri M, Belleri M, Locri F, Morbidelli L, Corsini M, Paganini G, Semeraro F, Cancarini A, Rusciano D, Presta M, Bagnoli P.

Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2392-407. doi: 10.1167/iovs.14-16323.

PMID:
25766585
36.

Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy.

Rezzola S, Dal Monte M, Belleri M, Bugatti A, Chiodelli P, Corsini M, Cammalleri M, Cancarini A, Morbidelli L, Oreste P, Bagnoli P, Semeraro F, Presta M.

Diabetes. 2015 Jul;64(7):2581-92. doi: 10.2337/db14-1378. Epub 2015 Feb 18.

37.

The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.

Liekens S, Noppen S, Gijsbers S, Sienaert R, Ronca R, Tobia C, Presta M.

Oncotarget. 2015 Mar 10;6(7):4633-48.

38.

Zebrafish embryo intersegmental vessels: a tool for investigating sprouting angiogenesis.

Tobia C, Gariano G, Guerra J, Presta M.

Methods Mol Biol. 2015;1214:173-84. doi: 10.1007/978-1-4939-1462-3_10.

PMID:
25468604
39.

Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance.

Rusnati M, Presta M.

Cytokine Growth Factor Rev. 2015 Jun;26(3):293-310. doi: 10.1016/j.cytogfr.2014.11.007. Epub 2014 Nov 20. Review.

PMID:
25465594
40.

Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model.

Van Raemdonck K, Berghmans N, Vanheule V, Bugatti A, Proost P, Opdenakker G, Presta M, Van Damme J, Struyf S.

Oncotarget. 2014 Nov 15;5(21):10916-33.

41.

Biosafe inertization of municipal solid waste incinerator residues by COSMOS technology.

Guarienti M, Gianoncelli A, Bontempi E, Moscoso Cardozo S, Borgese L, Zizioli D, Mitola S, Depero LE, Presta M.

J Hazard Mater. 2014 Aug 30;279:311-21. doi: 10.1016/j.jhazmat.2014.07.017. Epub 2014 Jul 18.

PMID:
25080155
42.

Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.

Ross JS, Wang K, Rand JV, Gay L, Presta MJ, Sheehan CE, Ali SM, Elvin JA, Labrecque E, Hiemstra C, Buell J, Otto GA, Yelensky R, Lipson D, Morosini D, Chmielecki J, Miller VA, Stephens PJ.

J Clin Pathol. 2014 Nov;67(11):968-73. doi: 10.1136/jclinpath-2014-202514. Epub 2014 Jul 30.

43.

Subperiosteal haematoma after general anaesthesia.

Saeed HN, Presta MV, Yoo D.

Br J Anaesth. 2014 Apr;112(4):772-3. doi: 10.1093/bja/aeu084. No abstract available.

44.

Molecular cloning and knockdown of galactocerebrosidase in zebrafish: new insights into the pathogenesis of Krabbe's disease.

Zizioli D, Guarienti M, Tobia C, Gariano G, Borsani G, Bresciani R, Ronca R, Giacopuzzi E, Preti A, Gaudenzi G, Belleri M, Di Salle E, Fabrias G, Casas J, Ribatti D, Monti E, Presta M.

Biochim Biophys Acta. 2014 Apr;1842(4):665-75. doi: 10.1016/j.bbadis.2014.01.008. Epub 2014 Jan 24.

45.

Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin.

Corsini M, Moroni E, Ravelli C, Andrés G, Grillo E, Ali IH, Brazil DP, Presta M, Mitola S.

Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):136-45. doi: 10.1161/ATVBAHA.113.302517. Epub 2013 Nov 14.

PMID:
24233491
46.

Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells.

Ronca R, Di Salle E, Giacomini A, Leali D, Alessi P, Coltrini D, Ravelli C, Matarazzo S, Ribatti D, Vermi W, Presta M.

Mol Cancer Ther. 2013 Dec;12(12):2760-71. doi: 10.1158/1535-7163.MCT-13-0487. Epub 2013 Oct 15.

47.

In vitro and ex vivo retina angiogenesis assays.

Rezzola S, Belleri M, Gariano G, Ribatti D, Costagliola C, Semeraro F, Presta M.

Angiogenesis. 2014 Jul;17(3):429-42. Review.

PMID:
24121991
48.

Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.

Belleri M, Ronca R, Coltrini D, Nico B, Ribatti D, Poliani PL, Giacomini A, Alessi P, Marchesini S, Santos MB, Bongarzone ER, Presta M.

Brain. 2013 Sep;136(Pt 9):2859-75. doi: 10.1093/brain/awt215.

49.

A novel ex vivo murine retina angiogenesis (EMRA) assay.

Rezzola S, Belleri M, Ribatti D, Costagliola C, Presta M, Semeraro F.

Exp Eye Res. 2013 Jul;112:51-6. doi: 10.1016/j.exer.2013.04.014. Epub 2013 Apr 27.

PMID:
23631846
50.

TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis.

Porcù E, Viola G, Bortolozzi R, Persano L, Mitola S, Ronca R, Presta M, Romagnoli R, Baraldi PG, Basso G.

Angiogenesis. 2013 Jul;16(3):647-62. doi: 10.1007/s10456-013-9343-z. Epub 2013 Mar 2.

PMID:
23456551

Supplemental Content

Loading ...
Support Center